CRISPR-phage antibacterials to address the antibiotic resistance crisis: scientific, economic, and regulatory considerations

Journal of Law and the Biosciences · Published 2024-01-01 · DOI 10.1093/jlb/lsad030

Authors being retrieved — see the publisher record. https://doi.org/10.1093/jlb/lsad030

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year: 2024

Related articles

Bacteriophage therapy in the era of antimicrobial resistance: clinical evidence, translational challenges, and emerging regulatory frameworks (2020–2026) · Exploration of Medicine · 2026 · Cites or is cited by this article
How do we justify research into enhanced warfighters? · Journal of Law and the Biosciences · 2024 · Same journal
Neural personal information and its legal protection: evidence from China · Journal of Law and the Biosciences · 2025 · Same journal
Chat M.D. · Journal of Law and the Biosciences · 2026 · Same journal
Alabama’s LePage decision, the future of ex vivo embryos, and more · Journal of Law and the Biosciences · 2026 · Same journal
‘Potato potahto’? Disentangling de-identification, anonymisation, and pseudonymisation for health research in Africa · Journal of Law and the Biosciences · 2025 · Same journal
Patents, genetic resources, and traditional knowledge: the WIPO treaty and the global access and benefit-sharing regime complex · Journal of Law and the Biosciences · 2026 · Same journal
Data ownership in genomic research consortia · Journal of Law and the Biosciences · 2024 · Same journal
Cross-border data sharing for research in Africa: an analysis of the data protection and research ethics requirements in 12 jurisdictions · Journal of Law and the Biosciences · 2025 · Same journal
The right to mental integrity in the age of neurotechnology: constructing scope and exploring permissible limitations · Journal of Law and the Biosciences · 2025 · Same journal